Donor-specific transfusion in living related and unrelated donor kidney transplantation: minimal sensitization and excellent graft outcome.
Kong
J M
JM
Department of Internal Medicine, Maryknoll Hospital, Pusan, South Korea.
Jeong
J H
JH
Kang
J K
JK
Seong
I G
IG
Kim
B C
BC
D000293:Adolescent; D000328:Adult; D000368:Aged; D001803:Blood Transfusion; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000097:blood / Q000627:therapeutic use; D006084:Graft Rejection / Q000097:blood / Q000175:diagnosis / Q000628:therapy; D006085:Graft Survival / Q000276:immunology*; D006650:Histocompatibility Testing; D006801:Humans; D007114:Immunization; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality / Q000502:physiology; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D016853:Muromonab-CD3 / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D015996:Survival Rate; D014019:Tissue Donors; D016896:Treatment Outcome
D016853:Muromonab-CD3; D016572:Cyclosporine; D003404:Creatinine; D011241:Prednisone; D008775:Methylprednisolone